Băncilă, Diaconu și Asociații SPRL assisted the founders of CytoGenomic Medical Laboratory in the sale of a majority stake to FutureLife

Băncilă, Diaconu și Asociații SPRL assisted the founders of CytoGenomic Medical Laboratory in the sale of a majority stake in CytoGenomic Medical Laboratory SRL, Romanian leading genetic laboratory and one of the most innovative providers of medical services, to FutureLife, an European leader in reproductive medicine.

Dr. Danae Stambouli, founder of CytoGenomic Medical Laboratory, will remain a significant shareholder and CEO, leading the company’s expansion strategy.

Danae Stambouli: "I am very pleased with the contribution of Băncilă, Diaconu și Asociații team to the completion of the transaction. I particularly appreciated their promptness, client-oriented approach, and commercial knowledge, which doubled their legal contribution and provided us with comfort throughout the negotiations."

Alexandra Siminiceanu, Managing Associate at Băncilă, Diaconu și Asociații SPRL: "We thank the founders of CytoGenomic Medical Laboratory for the trust placed in us throughout this transaction, as well as for the opportunity to support the company's development alongside a partner of the caliber of FutureLife."

The Băncilă, Diaconu și Asociații SPRL team that assisted CytoGenomic Medical Laboratory in this transaction consisted of Radu Diaconu (Managing Partner), Ștefan Mantea (Director), Alexandra Siminiceanu (Managing Associate) and Miruna Coderie (Senior Associate).